Tirzepatide
Description: Tirzepatide is a novel dual incretin receptor agonist that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is designed to support metabolic regulation by enhancing insulin secretion, reducing glucagon levels, delaying gastric emptying, and promoting satiety. Its dual-action mechanism differentiates it from traditional single-pathway GLP-1 analogs.
Compliance Notice:
For research use only. Not intended for human or veterinary use, medical treatment, or diagnostic applications. Users must comply with all applicable laws and regul
Research Applications:
Tirzepatide is widely used in metabolic and endocrinology research. It is studied for its effects on glucose metabolism, insulin sensitivity, appetite regulation, and body weight management. Due to its dual incretin activity, it is also utilized in research exploring obesity, type 2 diabetes, and related metabolic disorders.
Storage and Handling:
- Store at 2–8°C (refrigerated) for short-term use
- For long-term storage, keep at -20°C
- Protect from light and repeated freeze-thaw cycles
- Keep container tightly sealed when not in use
- Handle using appropriate laboratory safety and aseptic techniques
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: Lyophilized White Powder
Solubility: Soluble In Suitable Laboratory Agents
Compliance Notice:
Tirzepatide is intended for research purposes only. It is not designed for human or veterinary use and has not been evaluated by the FDA for commercial distribution in this form. Improper use is strictly prohibited and may violate federal, state, or local regulations. By purchasing this product, the buyer agrees that it will be used strictly for in vitro laboratory research. Not suitable for human consumption.
| Size |
5mg ,10mg ,15mg ,20mg ,30mg ,40mg ,50mg ,60mg ,80mg ,100mg ,120mg |
|---|

Reviews
There are no reviews yet.